Related references
Note: Only part of the references are listed.Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-β and IGF-II
Rosa Montes et al.
CELL RESEARCH (2009)
Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos
J. L. Cortes et al.
HUMAN REPRODUCTION (2009)
Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia
P. Catalina et al.
LEUKEMIA RESEARCH (2009)
Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential
Jolanta Libura et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?
Puri Catalina et al.
MOLECULAR CANCER (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Dietary flavonoids induce MLL translocations in primary human CD34+cells
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani et al.
CARCINOGENESIS (2007)
Conventional and molecular cytogenetic diagnostic methods in stem cell research: A concise review
Purificacion Catalina et al.
CELL BIOLOGY INTERNATIONAL (2007)
MLL chimeric protein activation renders cells vulnerable to chromosomal damage: An explanation for the very short latency of infant leukemia
Mariko Eguchi et al.
GENES CHROMOSOMES & CANCER (2006)
MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells
CG Moneypenny et al.
CARCINOGENESIS (2006)
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials
RE Gale et al.
BLOOD (2005)
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
R Ono et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Maternal diet and infant leukemia: The DNA topoisomerase II inhibitor hypothesis: A report from the Children's Oncology Group
LG Spector et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion
J Libura et al.
BLOOD (2005)
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes
C Meyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy
T Taketani et al.
BLOOD (2004)
Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45neg PFV hemogenic precursors
P Menendez et al.
MOLECULAR THERAPY (2004)
Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia
MJ Edick et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
International Workshop on the Relationship of Prior Therapy to Balanced Chromosome Aberrations in Therapy-Related Myelodysplastic Syndromes and Acute Leukemia: Overview report
JD Rowley et al.
GENES CHROMOSOMES & CANCER (2002)
Science, medicine, and the future - Childhood leukaemia
M Greaves
BRITISH MEDICAL JOURNAL (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
An atlas on chromosomes in hematological malignancies. Example: 11q23 and MLL partners
JL Huret et al.
LEUKEMIA (2001)
The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds
C Caslini et al.
LEUKEMIA (2000)
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
R Strick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)